glutathione injections phoenix IV Therapy IV Infusion Therapy in Phoenix

Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors

The uncropped and unprocessed scans are provided in the Source Data file

The combination of Methionine, Inositol, Choline, and Vitamin B12 targets fat metabolism and energy production in several ways: Enhanced Fat Metabolism: The lipotropic agents in the MIC injection help break down fat in the liver, promoting its use as energy rather than storage

This allows us to exclude these claims, similar to our methodology for clinical trial cases, in the calculation of the relative weight for MS-DRG 018, without relying on a proxy

Jill 32:04 Yes